Waseem Qureshi

Bariatric surgery improved outcomes in weight, triglycerides, HDL cholesterol, and quality of life compared with intensive medical therapy alone.

Aggressive antihypertensive treatment (<130 mm Hg) may not be necessary in patients with diabetes.

Routine screening for eating disorders may be necessary in patients with polycystic ovary syndrome.

Susannah L. Rose, PhD, shares insight into the prevalence of industry funding of advocacy groups and what clinicians should consider when interpreting research outcomes.

A case report suggested that combination therapy with growth hormone and anastrozole may improve final height in congenital adrenal hyperplasia.

Patients with type 2 diabetes that is uncontrolled on metformin plus a sulfonylurea may benefit from combination therapy with a GLP-1 receptor agonist and pioglitazone.

The American Association of Clinical Endocrinologists and the American College of Endocrinology are seeking to eliminate the stigma surrounding the term “obesity” and clarify information about obesity as a disease state.

Etelcalcetide shows promise for reducing parathyroid hormone in hemodialysis patients with secondary hyperparathyroidism.

Early detection and quick treatment with levothyroxine are essential in treating children with congenital hypothyroidism.

Katherine A. Roberts, MD, FACE, ECNU, discusses her experience with opting out of Medicare and offers advice to physicians considering doing the same.

Experts from more than 30 national and international societies have pledged to intensify efforts and collaborate to address the “crisis” in osteoporosis.

Evacetrapib did lower low-density lipoprotein cholesterol in high vascular risk patients, but did not reduce major cardiovascular events.

Results from the SPRINT trial, reported at the American Heart Association, suggest that lower systolic blood pressure targets may be more effective in lowering cardiovascular risk.

In a 10-5 vote, an FDA panel recommended against expanding indications for ezetimibe and ezetimibe/simvastatin.